Results 151 to 160 of about 4,093 (216)

Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study. [PDF]

J Atheroscler Thromb
Hirano T, Hayashi T, Sugita H, Tamasawa A, Ohara M, Terasaki M, Ito Y, Yamagishi SI, Mori Y.   +8 more
europepmc   +1 more source

Mediating Role of the ANGPTL3/TFPI Protein Ratio in Regulating T-Cell Surface Glycoprotein CD5 Levels on Knee Osteoarthritis (KOA): A Mendelian Randomization Study [PDF]

Y. H. Li, Xi Liao, Xi Yu, Ying Xiao, Xiaoyu Tao, Tian Zhong   +5 more
openalex   +1 more source

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies. [PDF]

Curr Cardiol Rep
Alam U, Mathai SV, Filtz A, Kuno T, Badimon JJ, Sniderman AD, Virani SS, Toth PP, Shapiro MD, Lavie CJ, Bhatt DL, Slipczuk L.   +11 more
europepmc   +1 more source

CRISPR and the Future of Cardiac Disease Therapy: A New Genetic Frontier. [PDF]

Int J Mol Sci
Sterckel S, Chávez Martínez IL, Schwach V.   +2 more
europepmc   +1 more source

10005: SREBP2 Depletion Protects against Hyperlipidemia and Atherosclerosis by Regulating ANGPTL3-LPL Axis

Yifan Wang, Jia You Sarafina Choe, Yu Shi, Thi Tun Thi, Kai Yan Cheng, Yang Hu, Hui Li, Xiaoyun Cao, Yang Ji, Yan Liu, Matthew Ackers‐Johnson, Yujia Shen, Haojie Yu   +12 more
openalex   +1 more source

Unveiling the PGAM5-ANGPTL3 Axis

JACC: Basic to Translational Science
openaire   +1 more source

Olezarsen and Beyond: Emerging Targeted Treatments for Familial Chylomicronemia Syndrome and Related Triglyceride Disorders. [PDF]

J Lipid Atheroscler
N M, C B K, D R S.
europepmc   +1 more source

Multi-omics data integration from patients with carotid stenosis illuminates key molecular signatures of atherosclerotic instability. [PDF]

Genome Med
Das V, Narayanan S, Zhang X, Bergman O, Djordjevic D, Kronqvist M, Chemaly M, Karadimou G, Sundman S, Prasad I, Buckler AJ, Knape KC, Michaelsen NB, Hedin U, Matic L.   +14 more
europepmc   +1 more source

New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9. [PDF]

Eur Heart J Suppl
Arnaboldi L, Tang Z, Ferri N, Corsini A.
europepmc   +1 more source

Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.

J Clin Endocrinol Metab
Gobeil É, Bourgault J, Gagnon E, Samson N, Ruel LJ, Côté V, Mitchell PL, Gotti C, Roux-Dalvai F, Droit A, Bossé Y, Mathieu P, Lajeunesse-Trempe F, Vohl MC, Caron A, Tchernof A, Thériault S, Laplante M, Arsenault BJ.   +18 more
europepmc   +1 more source